Response to Standard PBC Treatment at 1 Year Linked to Lower Long-Term Risks
(MedPage Today) -- A biochemical response to ursodeoxycholic acid (UDCA) at 12 months was associated with lower 5-year risks of hepatic decompensation and mortality in patients with primary biliary cholangitis (PBC), a propensity-matched landmark...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.